AstraZeneca Shares Hit Record High After Earnings Beat, U.S. Price Deal -- Market Talk

Dow Jones
2025/11/11

1338 GMT - AstraZeneca shares hit their highest level on record after third-quarter earnings last week beat market expectations. A U.S. drug-pricing deal reached last month that eased policy uncertainty also supports gains for the British pharma group, which makes more than 40% of its sales in the U.S. Shares rose 2.5% in early trading after climbing to an all-time intraday high of 134.6 pounds. Shares are now trading at 133.48 pounds, valuing the company at 203.3 billion pounds. AstraZeneca remains the largest U.K.-listed stock by market capitalization. (william.gray@wsj.com)

 

(END) Dow Jones Newswires

November 11, 2025 08:38 ET (13:38 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10